Department of Radiation Oncology, Michigan Medicine, Ann Arbor, Michigan.
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):219-228. doi: 10.1016/j.ijrobp.2022.06.071. Epub 2022 Oct 25.
Promoting a diverse workforce of health care professionals that delivers equitable patient care is an important goal in oncology, as in all of medicine. Although most medical schools have a diversity office and associated initiatives, little is known about radiation oncology (RO) department-level efforts to promote diversity, equity, and inclusion (DEI). We describe the current state of DEI leadership and initiatives in RO departments in the US to guide future policies and programs.
A total of 124 US RO departments affiliated with a medical school were contacted to identify departmental DEI leadership. Identified DEI leaders were asked to complete an anonymous survey assessing characteristics of their departmental DEI leadership, committee/organizational structure, activities, and perceived barriers to, and effect of, their work. Descriptive statistics are reported.
Among 85 RO departments that responded (68.5% response rate), 48 (56.5%) reported having a departmental DEI leader. Thirty-four DEI leaders completed the survey (70.8%). Of those who answered each survey question, most DEI leaders were assistant or associate professors (n = 24, 82.8%), women (n = 19, 73.1%), and identified with at least one non-White race or Hispanic ethnicity (n = 15, 53.6%). Nineteen (57.6%) had an associated departmental DEI committee; with 10 of these starting in 2020 or later. Few DEI leaders had administrative support (38.2%), funding (29.4%), protected time (23.5%), or increased compensation for added duties Fifteen (50.0%) believed their DEI-focused efforts were considered for promotion. The most reported initiatives included offering programming/education, supporting students from backgrounds underrepresented in medicine, improving recruitment practices/hiring, and implementing pipeline/pathway projects. The perceived impact of DEI initiatives included an increased culture of respect (89.7%), improved health care disparity awareness (75.9%), and improved systemic/structural racism awareness (79.3%).
Departmental DEI efforts are increasingly common within RO, however, the structure, resources, and recognition associated with DEI work are variable. Additional dedicated resources and recognition for these efforts will help ensure a culture of inclusive excellence for the RO workforce and patients.
在肿瘤学领域,如同在所有医学领域一样,培养一支多元化的医疗保健专业人员队伍,为患者提供公平的护理,是一个重要目标。尽管大多数医学院都设有多样性办公室和相关倡议,但对于放射肿瘤学(RO)部门在促进多样性、公平性和包容性(DEI)方面的努力,人们知之甚少。我们描述了美国 RO 部门 DEI 领导力和倡议的现状,以指导未来的政策和计划。
共联系了 124 家隶属于医学院的美国 RO 部门,以确定部门 DEI 领导力。确定的 DEI 领导者被要求完成一项匿名调查,评估其部门 DEI 领导力、委员会/组织结构、活动以及对其工作的障碍和影响。报告了描述性统计数据。
在 85 个做出回应的 RO 部门中(回应率为 68.5%),有 48 个(56.5%)报告称有部门 DEI 领导者。有 34 名 DEI 领导者完成了调查(70.8%)。在回答每个调查问题的人当中,大多数 DEI 领导者是助理教授或副教授(n=24,82.8%)、女性(n=19,73.1%),并自认为至少属于一个非白种人或西班牙裔种族(n=15,53.6%)。有 19 名(57.6%)有相关的部门 DEI 委员会;其中 10 个成立于 2020 年或之后。很少有 DEI 领导者得到行政支持(38.2%)、资金(29.4%)、受保护的时间(23.5%)或增加额外职责的报酬。有 15 名(50.0%)认为他们的 DEI 重点工作被考虑晋升。报告最多的举措包括提供编程/教育、支持医学背景代表性不足的学生、改善招聘实践/招聘、以及实施人才储备/途径项目。DEI 举措的预期影响包括增强尊重文化(89.7%)、提高对医疗保健差距的认识(75.9%)以及提高对系统性/结构性种族主义的认识(79.3%)。
在 RO 领域,部门的 DEI 工作越来越普遍,但与 DEI 工作相关的结构、资源和认可各不相同。为这些工作提供更多的专用资源和认可将有助于确保 RO 劳动力和患者的包容性卓越文化。